Epirubicin
Autologous Stem Cell Transplant
Masonic Cancer Center, University of MinnesotaPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 89/ 100
Competitive context
11 Active assets in the Autologous Stem Cell Transplant cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
mln9708 Takeda | Phase 3 | B |
Bendamustine Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | Phase 2 | B |
Cytosin-Arabinosid Masonic Cancer Center, University of Minnesota | Phase 2 | CCC |
Cyclophosphamide Masonic Cancer Center, University of Minnesota | Phase 2 | CCC |
ETOPOSIDE Masonic Cancer Center, University of Minnesota | Phase 2 | CCC |
View all 13 →
Same molecule, other indications
Epirubicin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →